Bullous pemphigoid and COVID-19 vaccine.

dc.contributor.authorPérez-López, Israel
dc.contributor.authorMoyano-Bueno, David
dc.contributor.authorRuiz-Villaverde, Ricardo
dc.date.accessioned2025-01-07T13:59:40Z
dc.date.available2025-01-07T13:59:40Z
dc.date.issued2021-05-27
dc.identifier.doi10.1016/j.medcli.2021.05.005
dc.identifier.essn1578-8989
dc.identifier.pmcPMC8157120
dc.identifier.pmid34119340
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8157120/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.medcli.2021.05.005
dc.identifier.urihttps://hdl.handle.net/10668/26029
dc.issue.number10
dc.journal.titleMedicina clinica
dc.journal.titleabbreviationMed Clin (Barc)
dc.language.isoen
dc.language.isoes
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationSAS - Hospital Universitario San Cecilio
dc.page.numbere333-e334
dc.pubmedtypeLetter
dc.rights.accessRightsopen access
dc.subject.meshCOVID-19
dc.subject.meshCOVID-19 Vaccines
dc.subject.meshHumans
dc.subject.meshPemphigoid, Bullous
dc.subject.meshSARS-CoV-2
dc.titleBullous pemphigoid and COVID-19 vaccine.
dc.title.alternativePenfigoide ampolloso y vacuna COVID-19.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number157

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC8157120.pdf
Size:
486.73 KB
Format:
Adobe Portable Document Format